Showing results (51-60 of 97) with videos related to

Sort By:
Pageof 10
BMC Cancer|April 14, 2022
Four cycles of R-CHOP followed by two applications of rituximab based on negative interim PET/CT: an analysis of a prospective trialJia Jin, Dongmei Ji, Zuguang Xia, et al.
Iscience|January 13, 2022
Therapeutic exosomal vaccine for enhanced cancer immunotherapy by mediating tumor microenvironmentFangfang Lv, Huifang Liu, Gaoqian Zhao, et al.
Frontiers in Microbiology|March 5, 2021
The Epidemiology, Molecular, and Clinical of Human Adenoviruses in Children Hospitalized With Acute Respiratory InfectionsShunhang Wen, Zupan Lin, Yue Zhang, et al.
ACS Applied Materials & Interfaces|July 3, 2020
Prodrug-Based Nanoreactors with Tumor-Specific In Situ Activation for Multisynergistic Cancer TherapyCui Ren, Huifang Liu, Fangfang Lv, et al.
ACS Applied Bio Materials|January 15, 2022
Mesoporous Platinum Nanotherapeutics for Combined Chemo-photothermal Cancer TreatmentWencong Zhao, Zhenhua Li, Hua Yang, et al.
Cancer Medicine|August 29, 2024
Chidamide plus R-GDP for relapsed/refractory diffuse large B-cell lymphoma in patients ineligible for autologous transplantation: A prospective, single-arm, phase II studyGuang-Liang Chen, Kai Xue, Qunling Zhang, et al.
BMC Cancer|October 7, 2010
Safety and pharmacokinetics of novel selective vascular endothelial growth factor receptor-2 inhibitor YN968D1 in patients with advanced malignanciesJin Li, Xinmin Zhao, Lei Chen, et al.
Cancer Chemotherapy and Pharmacology|January 10, 2015
Endostar in combination with modified FOLFOX6 as an initial therapy in advanced colorectal cancer patients: a phase I clinical trialZhiyu Chen, Weijian Guo, Junning Cao, et al.
Oncotarget|April 30, 2016
Thalidomide enhanced the efficacy of CHOP chemotherapy in the treatment of diffuse large B cell lymphoma: A phase II studyDongmei Ji, Qiu Li, Junning Cao, et al.
International Journal of Hematology|May 10, 2022
Hexokinase II expression as a prognostic marker in diffuse large B-cell lymphoma: pre- and post-rituximab eraJia Jin, Ailing Gui, Guangliang Chen, et al.
Pageof 10